Literature DB >> 26604277

Pharmacokinetics and Pharmacodynamics of Biosimilar Insulins: Is Clamp Technology Fit for Purpose?

Philip Home1.   

Abstract

Year:  2015        PMID: 26604277     DOI: 10.2337/dc15-1046

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  5 in total

1.  Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study.

Authors:  Yi Tao; Mingxue Zhu; Junliang Pu; Peilin Zhang; Lei Wan; Chengyong Tang
Journal:  Front Pharmacol       Date:  2021-12-02       Impact factor: 5.810

2.  Effects of Unsuppressed Endogenous Insulin on Pharmacokinetics and/or Pharmacodynamics of Study Insulin in the Healthy: A Retrospective Study.

Authors:  Hui Liu; Hongling Yu; Lisi Sun; Jingtao Qiao; Jiaqi Li; Huiwen Tan; Yerong Yu
Journal:  Clin Pharmacol Drug Dev       Date:  2022-04-05

3.  Insulin's Role in Diabetes Management: After 90 Years, Still Considered the Essential "Black Dress".

Authors:  William T Cefalu; Julio Rosenstock; Derek LeRoith; Matthew C Riddle
Journal:  Diabetes Care       Date:  2015-12       Impact factor: 19.112

4.  Pediatric Insulin Injection Technique: A Multi-Country Survey and Clinical Practice Implications.

Authors:  Sanjay Kalra; Laurence J Hirsch; Anders Frid; Asma Deeb; Kenneth W Strauss
Journal:  Diabetes Ther       Date:  2018-09-21       Impact factor: 2.945

5.  The Injection Technique Factor: What You Don't Know or Teach Can Make a Difference.

Authors:  Laurence J Hirsch; Kenneth W Strauss
Journal:  Clin Diabetes       Date:  2019-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.